Title : Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.

Pub. Date : 2006 Oct

PMID : 16845661






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The mTOR inhibitor, rapamycin (sirolimus), reduces disease severity in rodent models of TSC, and is currently in phase II clinical trials. Sirolimus TSC complex subunit 1 Mus musculus
2 The mTOR inhibitor, rapamycin (sirolimus), reduces disease severity in rodent models of TSC, and is currently in phase II clinical trials. Sirolimus TSC complex subunit 1 Mus musculus